研究者業績

中井 剛

ナカイ ツヨシ  (Tsuyoshi Nakai)

基本情報

所属
藤田医科大学  医学部・薬物治療情報学  講師
学位
博士(医学)(名古屋大学)

ORCID ID
 https://orcid.org/0009-0005-2667-7057
J-GLOBAL ID
202001000562143382
researchmap会員ID
R000010558

論文

 19
  • AKIHIKO FUTAMURA, TAKENAO KOSEKI, TSUYOSHI NAKAI, NOBUYUKI MUROI, MICHIAKI MYOTOKU, JUNICHI IIDA, HIROKI MAKI, AKITO SUZUKI, KAZUHISA MIZUTANI, HIKARU OGINO, YASUKI TANIGUCHI, KEIICHIRO HIGASHI, MASANOBU USUI
    In Vivo 38(6) 3041-3049 2024年10月29日  査読有り
  • Geyao Dong, Tsuyoshi Nakai, Tetsuo Matsuzaki
    FEBS Open Bio 1-17 2024年10月10日  査読有り
    The budding yeast Saccharomyces cerevisiae is commonly used as an expression platform for the production of valuable compounds. Yeast‐based genetic research can uniquely utilize auxotrophy in transformant selection: auxotrophic complementation by an auxotrophic marker gene on exogenous DNA (such as plasmids). However, the number of required auxotrophic nutrients restricts the number of plasmids maintained by the cells. We, therefore, developed novel Δ10 strains that are auxotrophic for 10 different nutrients and new plasmids with two multiple cloning sites and auxotrophic markers for use in Δ10 strains. We confirmed that Δ10 strains were able to maintain 10 types of plasmids. Using plasmids encoding model proteins, we detected the co‐expression of 17 different genes in Δ10 cell lines. We also constructed Δ9 strains that exhibited auxotrophy for nine nutrients and increased growth compared to Δ10. This study opens a new avenue for the co‐expression of a large number of genes in eukaryotic cells.
  • NANAMI KATO, TSUYOSHI NAKAI, SACHIYO KODAMA, SACHIKO KOYAMA, SHIGEKI NAKANE, YASUHIRO WADA, HIROSHI ODA, HIROMI KATAYAMA, HIROKI MASE, YASUHIRO MIYAGAWA, MASAYUKI MIYAZAKI, SHIGEKI YAMADA, KIYOFUMI YAMADA
    In Vivo 38(3) 1243-1252 2024年4月30日  査読有り筆頭著者
  • Noriaki Matsumoto, Tomohiro Mizuno, Yosuke Ando, Koki Kato, Masanori Nakanishi, Tsuyoshi Nakai, Jeannie K. Lee, Yoshitaka Kameya, Wataru Nakamura, Kiyoshi Takahara, Ryoichi Shiroki, Shigeki Yamada
    Clinical Drug Investigation 44(4) 2024年4月29日  査読有り
  • Noriaki Matsumoto, Tsuyoshi Nakai, Mikio Sakakibara, Yukinori Aimiya, Shinya Sugiura, Jeannie K. Lee, Shigeki Yamada, Tomohiro Mizuno
    Scientific Reports 14(1) 1-10 2024年1月30日  査読有り
    Abstract Hypertension is a major cause of cardiovascular diseases. Several recent studies reported that pharmacists’ remote follow-up reduced hypertension patients’ blood pressure (BP). This meta-analysis aims to verify whether remote follow-up by pharmacists improves BP levels and reveal the factors that make the intervention effective. The search, conducted using PubMed/Medline, Embase, and Cochrane Library from June to July 2023, targeted articles published between October 1982 and June 2023, using terms including “pharmacist”, “hypertension”, and “randomized controlled trial (RCT)”. The inclusion criteria were: (a) RCTs involving hypertension patients with or without comorbidities, (b) pharmacists using remote communication tools to conduct follow-up encounter during the intervention period, (c) reporting systolic blood pressure (SBP) at baseline and during intervention. SBP was the primary outcome for the meta-analysis. Thirteen studies (3969 participants) were included in this meta-analysis. The mean difference of SBP between intervention group and control group was − 7.35 mmHg (P < 0.0001). Subgroup analyses showed the greater reduction of SBP in the “regularly scheduled follow-up cohort” (− 8.89 mmHg) compared with the “as needed follow-up cohort” (− 3.23 mmHg, P < 0.0001). The results revealed that remote follow-up by pharmacists reduced SBP levels in hypertension patients and scheduled remote follow-up may contribute to the effectiveness.

MISC

 39

書籍等出版物

 1

講演・口頭発表等

 61

所属学協会

 8

共同研究・競争的資金等の研究課題

 8

産業財産権

 2

社会貢献活動

 1